David Wambeke
Corporate Officer/Principal chez DIAMEDICA THERAPEUTICS INC.
Fortune : 3 M $ au 30/06/2024
Profil
David John Wambeke is currently the Chief Business Officer at DiaMedica Therapeutics, Inc. He previously worked as a Partner & Managing Director at Craig-Hallum Capital Group LLC.
He completed his undergraduate degree at the University of Minnesota.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 01/06/2024 | 527 114 ( inf% ) | 2 M $ | 30/06/2024 | |
| 01/06/2024 | 527 114 ( 1,39% ) | 2 M $ | 30/06/2024 |
Postes actifs de David Wambeke
| Sociétés | Poste | Début |
|---|---|---|
| DIAMEDICA THERAPEUTICS INC. | Corporate Officer/Principal | 11/04/2023 |
Anciens postes connus de David Wambeke
| Sociétés | Poste | Fin |
|---|---|---|
Craig-Hallum Capital Group LLC
 Craig-Hallum Capital Group LLC Investment Banks/BrokersFinance Craig-Hallum Capital Group LLC (Craig-Hallum) is an employee-owned, idea-driven research, trading and investment banking firm headquartered in Minneapolis, Minnesota. The firm was founded by Bradley Baker and Kevin Harris in 1997. Craig-Hallum provides research, institutional sales and trading and investment banking services to institutional investors and growth companies. | Analyst-Equity | 01/03/2023 |
Formation de David Wambeke
| University of Minnesota | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| DIAMEDICA THERAPEUTICS INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Craig-Hallum Capital Group LLC
Craig-Hallum Capital Group LLC Investment Banks/BrokersFinance Craig-Hallum Capital Group LLC (Craig-Hallum) is an employee-owned, idea-driven research, trading and investment banking firm headquartered in Minneapolis, Minnesota. The firm was founded by Bradley Baker and Kevin Harris in 1997. Craig-Hallum provides research, institutional sales and trading and investment banking services to institutional investors and growth companies. | Finance |
